News Focus
News Focus
Followers 2
Posts 324
Boards Moderated 0
Alias Born 07/29/2006

Re: nerdseeksblonde post# 4493

Sunday, 07/08/2007 3:59:29 PM

Sunday, July 08, 2007 3:59:29 PM

Post# of 12660
I think this is litigation fallout, no?

http://www.sec.gov/Archives/edgar/data/1072379/000089102007000163/v30743e8vk.htm#102

Cost Recovery
The Company has submitted an application to the U.S. Food and Drug Administration (“FDA”) for cost recovery for its Phase II pivotal trial in brain cancer. If this application is granted, the Company will be permitted to charge patients or their insurers for the direct manufacturing costs of DCVax®-Brain during this clinical trial. Cost recovery is an extraordinary measure, and is only allowed in rare cases involving certain kinds of special circumstances. The Company considers its cost recovery application to FDA extremely important and central to the timing and overall implementation of its product development programs. The Company expects to receive a decision from the FDA on its cost recovery application in the near future.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today